VARIABLES | GROUP A (n = 41) | GROUP B (n = 35) | GROUP C (n = 45) | p value |
---|---|---|---|---|
Age | 60,8 +/- 11 | 59,6 +/- 12 | 54 +/- 12 | 0,038 |
Gender (male %) | 51,2 | 54,2 | 65 | 0,47 |
Reasons for test: | ||||
-Investigation for CAD (%) | 46 | 66 | 55 | 0,23 |
-Evaluation of known CAD (%) | 54 | 34 | 45 | 0,23 |
Hypertension (%) | 61 | 62 | 45 | 0,61 |
Diabetes (%) | 20 | 20 | 21 | 0,98 |
Hyperlipemia (%) | 46 | 62 | 35 | 0,10 |
Family history for CAD (%) | 49 | 60 | 46 | 0,49 |
Smoking (%) | 29 | 31 | 24 | 0,80 |
Obesity (%) | 36 | 28 | 45 | 0,40 |
Use of Beta-blocker (%) | 49 | 54 | 45 | 0,74 |
Use of Calcium blocker (%) | 12 | 20 | 10 | 0,48 |
Altered baseline ECG (%) | 38 | 39 | 41 | 0,97 |
Altered baseline Echo (%) | 41 | 37 | 42 | 0,87 |
Normal LV function (%) | 66 | 86 | 65 | 0,097 |
Previous angiography (%) | 46 | 40 | 36 | 0,68 |
Previous PTCA (%) | 19 | 12 | 10 | 0,60 |
Previous CABG (%) | 17 | 17 | 10 | 0,69 |